M. Zelefsky

发表

Impact of Intraoperative Edema During Transperineal Permanent Prostate Brachytherapy on Computer-Optimized and Preimplant Planning Techniques

Y. Yamada, L. Potters, M. Zaider, 2003, American journal of clinical oncology.

Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy.

Y. Yamada, M. Zaider, G. Cohen, 2003, International journal of radiation oncology, biology, physics.

Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society.

Y. Yu, M. Zelefsky, R. Cormack, 2001, International journal of radiation oncology, biology, physics.

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.

L. Egevad, J. Eastham, M. Zelefsky, 2016, European urology.

Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.

M. Terris, M. Cooperberg, P. Carroll, 2020, JAMA oncology.

Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging.

M. Zaider, G. Cohen, M. Zelefsky, 2000, International journal of radiation oncology, biology, physics.

Combined 3‐dimensional conformal radiotherapy and transperineal Pd‐103 permanent implantation for patients with intermediate and unfavorable risk prostate cancer

M. Zelefsky, A. Singh, A. Raben, 2000, International journal of cancer.

Comparison of outcome and morbidity of 3-dimensional conformal radiotherapy versus transperineal permanent I-125 implantation for early stage prostatic cancer

K. Wallner, M. Zelefsky, A. Raben, 1998 .

Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

D. Kuban, M. Zelefsky, A. Zietman, 2003, International journal of radiation oncology, biology, physics.

Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer.

K. Wallner, M. Zelefsky, A. Raben, 2000, International journal of radiation oncology, biology, physics.

Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique.

Y. Yamada, M. Zaider, G. Cohen, 2000, International journal of radiation oncology, biology, physics.

Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate.

C. Ling, R. Mohan, M. Zelefsky, 1997, International journal of radiation oncology, biology, physics.

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.

Oliver Sartor, John Trachtenberg, Michel Rossignol, 2007, The Journal of urology.

Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer.

Marco Zaider, Yoshiya Yamada, Y. Yamada, 2007, International journal of radiation oncology, biology, physics.

Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.

Y. Yamada, M. Zelefsky, H. Amols, 2008, International journal of radiation oncology, biology, physics.

Intraoperative dynamic dosimetry for prostate implants.

M. Zaider, G. Cohen, M. Zelefsky, 2003, Physics in medicine and biology.

A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer.

V. Laudone, P. Scardino, J. Eastham, 2017, Urology.

Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer

M. Zelefsky, 2005 .

Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response.

C. Ling, E. Venkatraman, M. Zelefsky, 2000, International journal of radiation oncology, biology, physics.

Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.

L. Potters, M. Zelefsky, R. Stock, 2005, Brachytherapy.

Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer.

M. Zelefsky, R. Munbodh, A. Jackson, 2008, Medical physics.

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

M. Zelefsky, J. Coleman, B. Carver, 2012, International journal of radiation oncology, biology, physics.

Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: implications for defining postradiotherapy urinary toxicity.

E. Yorke, M. Zelefsky, J. Deasy, 2013, European urology.

Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer.

E. Yorke, M. Zelefsky, J. Deasy, 2014, International journal of radiation oncology, biology, physics.

Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience.

Suzanne L Wolden, J. Shah, M. Zelefsky, 2012, International journal of radiation oncology, biology, physics.

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer.

M W Kattan, S A Leibel, M. Kattan, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensity-modulated radiation therapy: supportive data for prostate cancer.

Margie Hunt, M. Zelefsky, M. Hunt, 2008, Seminars in radiation oncology.

Modeling positioning uncertainties of prostate cancer external beam radiation therapy using pre-treatment data.

J. Mechalakos, M. Zelefsky, J. Deasy, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.

C C Ling, A Jackson, S A Leibel, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

C C Ling, S A Leibel, Z Fuks, 2001, The Journal of urology.

Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy.

Marcel van Herk, C Clifton Ling, James G Mechalakos, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

New wine in an old bottle? Dose escalation under dose-volume constraints: a model of conformal therapy of the prostate.

G J Kutcher, C C Ling, S A Leibel, 1996, International journal of radiation oncology, biology, physics.

Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate.

G J Kutcher, S A Leibel, Z Fuks, 1997, International journal of radiation oncology, biology, physics.

Development of a semi-automatic alignment tool for accelerated localization of the prostate.

James Mechalakos, Timothy Hollister, C. Ling, 2003, International journal of radiation oncology, biology, physics.

A study of the effects of internal organ motion on dose escalation in conformal prostate treatments.

C Clifton Ling, Gig S Mageras, Laura Happersett, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

G J Kutcher, C C Ling, A Jackson, 2001, International journal of radiation oncology, biology, physics.

Variation in prostate position: Quantitation and implications for three-dimensional conformal radiation therapy

Gerald J. Kutcher, Michael J. Zelefsky, Bernard Baldwin, 1993 .

Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy

M. Zelefsky, G. Krol, H. Scher, 1992, Cancer.

Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

T LoSasso, C C Ling, C S Chui, 2001, International journal of radiation oncology, biology, physics.

Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients.

M. Zelefsky, D. Spratt, 2013, Brachytherapy.

Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate Cancer.

M. Zelefsky, B. Mychalczak, L. Happersett, 2019, International journal of radiation oncology, biology, physics.

Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data

M. Zelefsky, X. Pei, S. McBride, 2019, Advances in radiation oncology.

Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer.

M. Zelefsky, L. Happersett, D. Goldman, 2020, European urology oncology.

Overview of Tumor Control Outcomes with Prostate SBRT for Low and Intermediate Risk Prostate Cancer and Comparison to Other Treatment Interventions

M. Zelefsky, A. Taggar, P. Mann, 2018, Stereotactic Radiosurgery for Prostate Cancer.

Evaluation of Adherence to Quality Measures for Prostate Cancer Radiotherapy in the United States: Results from the Quality Research in Radiation Oncology (QRRO) Survey.

M. Zelefsky, A. Zietman, W. Lee, 2013, Practical radiation oncology.

1008 Correlation of DVH and treatment planning variables with late rectal bleeding after 3D-CRT of prostate cancer: What is the best way to define the rectal length and volume?

C. Ling, M. Zelefsky, C. Burman, 1999 .

Report of the American Society for Therapeutic Radiology and Oncology Working Group on the scope of radiation oncology (SCOPE).

M. Dewhirst, M. Zelefsky, J. Ajani, 2002, International journal of radiation oncology, biology, physics.

The Impact of MRI Training on Improvement of CT Based Post Implant Dosimetry: A Six Physician Study

W. R. Lee, M. Zelefsky, P. McLaughlin, 2005 .

SU-FF-I-21: Can Prostate CT Contouring Be Improved?

M. Zelefsky, P. McLaughlin, V. Narayana, 2005 .

Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.

Marco Zaider, Yoshiya Yamada, Y. Yamada, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity

G. Cohen, M. Zelefsky, A. Damato, 2021, BJU international.

Real-time intraoperative evaluation of implant quality and dose correction during prostate brachytherapy consistently improves target coverage using a novel image fusion and optimization program.

G. Mageras, M. Zaider, G. Cohen, 2017, Practical radiation oncology.

Long‐term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma

M. Zelefsky, L. Harrison, J. Armstrong, 1992, Cancer.

Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome.

E. Strong, M. Zelefsky, D. Pfister, 1992, Radiology.

Performance status after treatment for squamous cell cancer of the base of tongue--a comparison of primary radiation therapy versus primary surgery.

M. Zelefsky, L. Harrison, J. Gaynor, 1994, International journal of radiation oncology, biology, physics.

Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer.

T. Jang, M. Zelefsky, E. Basch, 2007, International journal of radiation oncology, biology, physics.

Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis

Margie Hunt, Jing Zhang, Neelam Tyagi, 2017, Physics in medicine and biology.

Predictors for Post-treatment Biopsy Outcomes after Prostate Stereotactic Body Radiotherapy.

M. Zelefsky, V. Reuter, S. Fine, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical experience and workflow challenges with magnetic resonance-only radiation therapy simulation and planning for prostate cancer

M. Zelefsky, K. Zakian, L. Happersett, 2020, Physics and imaging in radiation oncology.

Early Tolerance Outcomes of Stereotactic Hypofractionated Accelerated Radiation Therapy Concomitant with Pelvic Node Irradiation in High-risk Prostate Cancer

M. Zelefsky, L. Happersett, S. McBride, 2019, Advances in radiation oncology.

Limb salvage in soft tissue sarcomas involving neurovascular structures using combined surgical resection and brachytherapy.

M. Zelefsky, M. Brennan, D. Nori, 1990, International journal of radiation oncology, biology, physics.

A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer.

Y. Yamada, M. Zaider, G. Cohen, 2012, Brachytherapy.

11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series

J. Humm, M. Zelefsky, M. Morris, 2019, The Journal of Nuclear Medicine.

Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer.

J. Mechalakos, J. Shah, M. Zelefsky, 2011, International journal of radiation oncology, biology, physics.

Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.

P. Scardino, J. Eastham, Y. Yamada, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brain metastases from carcinoma of bladder.

M. Zelefsky, A. Steinfeld, 1987, Urology.

Long-term subjective functional outcome of surgery plus postoperative radiotheraphy for advanced stage oral cavity and oropharyngeal carcinoma.

E. Strong, J. Shah, M. Zelefsky, 1996, American journal of surgery.

A survival model for fractionated radiotherapy with an application to prostate cancer.

A. Yakovlev, L. Hanin, M. Zaider, 2001, Physics in medicine and biology.

Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?

H. Hricak, J. Eastham, M. Zelefsky, 2016, Urologic oncology.

Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases.

K. Rosenzweig, Y. Yamada, M. Zelefsky, 2011, International journal of radiation oncology, biology, physics.

Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer.

M. Zelefsky, R. Stock, R. Baser, 2014, The Journal of urology.

High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.

J. Shah, M. Zaider, G. Cohen, 2007, Brachytherapy.

How to select the optimal therapy for early-stage prostate cancer.

M. Zelefsky, M. Kollmeier, Marisa A Kollmeier, 2012, Critical reviews in oncology/hematology.

What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer?

M. Zelefsky, M. Kollmeier, 2008, Nature Clinical Practice Urology.

Intraoperative Radiation Therapy During Breast-Conserving Surgery; the Memorial Sloan—Kettering Cancer Center Technique

G. Cohen, M. Zelefsky, K. Beal, 2009 .

Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results.

G. Cohen, M. Zelefsky, K. Beal, 2007, International journal of radiation oncology, biology, physics.

Prognostic Value of Pretreatment MRI in Patients With Prostate Cancer Treated With Radiation Therapy: A Systematic Review and Meta-Analysis.

H. Hricak, M. Zelefsky, H. Vargas, 2019, AJR. American journal of roentgenology.

Ten‐year outcomes of high‐dose, intensity‐modulated radiotherapy for localized prostate cancer

Y. Yamada, M. Zelefsky, B. Cox, 2011, Cancer.

Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients.

G. Cohen, M. Zelefsky, M. Bains, 2013, Brachytherapy.

Pretreatment N omogram f or P redicting t he O utcome of T hree-Dimensiona l C onformal R adiotherapy i n Prostate C ancer

M. Kattan, P. Scardino, M. Zelefsky, 2000 .

CLINICAL UROLOGY: Letters to the EditorRE: HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED CANCER

C. Ling, E. Venkatraman, M. Zelefsky, 2001 .

Combined surgical resection and iridium 192 implantation for locally advanced and recurrent desmoid tumors

M. Zelefsky, L. Harrison, M. Brennan, 1991, Cancer.

Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.

M. Zelefsky, N. Lee, M. Rivera, 2009, International journal of radiation oncology, biology, physics.

Long‐term regional control in the observed neck following definitive chemoradiation for node‐positive oropharyngeal squamous cell cancer

J. Shah, M. Zelefsky, D. Kraus, 2013, International journal of cancer.

Volume and landmark analysis: comparison of MRI measurements obtained with an endorectal coil and with a phased-array coil.

H. Hricak, M. Zelefsky, O. Akin, 2015, Clinical radiology.

Three-dimensional conformal brachytherapy for prostate cancer

M. Zelefsky, 2004, Current urology reports.

Improved long-term outcomes with IMRT: is it better technology or better physics?

M. Zelefsky, J. Deasy, 2013, International journal of radiation oncology, biology, physics.

In response to Drs. Schulz and Kagan

M. Zelefsky, S. Leibel, 2003 .

Rectal bleeding after conformal radiotherapy of prostate cancer and dose volume histograms

C. Ling, M. Zelefsky, C. Burman, 1998 .

Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy.

K. Rosenzweig, Y. Yamada, M. Zelefsky, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Utility of FDG‐PET in clinical neuroendocrine prostate cancer

M. Zelefsky, D. Spratt, J. Osborne, 2014, The Prostate.

Biochemical response to androgen deprivation therapy before external beam radiation therapy predicts long-term prostate cancer survival outcomes.

M. Zelefsky, D. Gomez, X. Pei, 2013, International journal of radiation oncology, biology, physics.

Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer.

M. Zelefsky, A. Zietman, M. Roach, 2002, International journal of radiation oncology, biology, physics.

Comparing contemporary surgery to external-beam radiotherapy for clinically localized prostate cancer.

M. Zelefsky, S. Leibel, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III Multi-Center, Prospective, Randomized Trial Comparing Single Dose 24 Gy Radiotherapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer.

Y. Yamada, M. Zelefsky, M. Bilsky, 2021, International journal of radiation oncology, biology, physics.

Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging.

H. Hricak, P. Scardino, M. Zaider, 2009, International journal of radiation oncology, biology, physics.

Regarding the Focal Treatment of Prostate Cancer: Inference of the Gleason Grade From MR Spectroscopic Imaging

H. Hricak, M. Zaider, M. Zelefsky, 2007 .

Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis

Y. Yamada, M. Zelefsky, N. Lee, 2022, JCO oncology practice.

Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer

R. Spiro, E. Strong, J. Shah, 1996, Head & neck.

Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue

E. Strong, J. Shah, M. Zelefsky, 1998, Head & neck.

Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911)

M. Zelefsky, 2006 .

Which patients with prostate cancer benefit from immediate postoperative radiotherapy?

M. Zelefsky, B. Cox, 2008, Nature Clinical Practice Oncology.

Localizing sites of disease in patients with rising PSA up to 1 ng/mL following prostatectomy: how much information can conventional imaging provide?

H. Hricak, J. Eastham, M. Zelefsky, 2016 .

Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer.

M. Zelefsky, J. White, J. Wilson, 2009, Journal of the American College of Radiology : JACR.

Genitourinary Oncology Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing

D. Kuban, L. Potters, M. Zelefsky, 2016 .

Prostate Cancer: Alternative TherapyReply

M. Zaider, G. Cohen, M. Zelefsky, 2011 .

Simultaneous MV‐kV imaging for intrafractional motion management during volumetric‐modulated arc therapy delivery*

G. Mageras, M. Zelefsky, M. Hunt, 2016, Journal of applied clinical medical physics.

Long-term Neck Control Rates After Complete Response to Chemoradiation in Patients With Advanced Head and Neck Cancer

J. Shah, M. Zelefsky, L. Ben-Porat, 2007, American journal of clinical oncology.

Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models.

C. Ling, W. Schlegel, E. Venkatraman, 2000, International journal of radiation oncology, biology, physics.

Chapter 6 – Three-Dimensional and Conformal Treatment Planning

C. Ling, M. Zelefsky, C. Chui, 2002 .

Coping with prostate and seminal vesicle motion in three-dimensional conformal radiation therapy

M. Zelefsky, S. Leibel, G. Kutcher, 1994 .

Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference?

M. Zelefsky, L. Happersett, Pengpeng Zhang, 2020, Radiation oncology.

Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy.

M van Herk, G J Kutcher, C C Ling, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.

Y. Yamada, M. Zelefsky, L. Happersett, 2011, European urology.

Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis.

Y. Yamada, M. Zelefsky, S. Fine, 2013, International journal of radiation oncology, biology, physics.

Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer

M. Zelefsky, B. Mychalczak, A. Marciscano, 2020, Advances in radiation oncology.

Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.

Y. Yamada, M. Zelefsky, D. Spratt, 2015, The Journal of urology.

Postoperative radiotherapy for oral cavity cancers: Impact of anatomic subsite on treatment outcome

R. Spiro, E. Strong, J. Shah, 1990, Head & neck.

Double‐Blind, Placebo‐Controlled, Randomized Trial of Granulocyte‐Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer

J. Shah, M. Zelefsky, A. Vickers, 2006, Cancer journal.

Early biochemical predictors of survival in intermediate and high-risk prostate cancer treated with radiation and androgen deprivation therapy.

M. Zelefsky, A. Knezevic, S. McBride, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Rebuttal from Author re: Michel Bolla. Clinical Stage T3 Prostate Cancer: The Added Value of Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy. Eur Urol 2008;53:1104–6

M. Zelefsky, 2008 .

Pretreatment N omogram T hat P redicts 5 -Year P robability o f Metastasis F ollowing T hree-Dimensiona l C onformal R adiation Therapy f or L ocalized P rostate C ancer

M. Kattan, P. Scardino, M. Zelefsky, 2003 .

Impact of Transurethral Resection on the Long-Term Outcome of Patients with Prostatic Carcinoma

K. Wallner, M. Zelefsky, S. Leibel, 1993 .

Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results

Lawrence H. Schwartz, Michael J. Zelefsky, Oguz Akin, 2011, European Radiology.

Conventional external beam radiation therapy for prostatic cancer: where do we go from here?

M. Zelefsky, S. Leibel, Z. Fuks, 1993, International journal of radiation oncology, biology, physics.

Local Failure after Prostate SBRT Predominantly Occurs in the PI-RADS 4 or 5 Dominant Intraprostatic Lesion.

M. Zelefsky, A. Wibmer, S. McBride, 2022, European urology oncology.

A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy

Y. Yamada, G. Cohen, M. Zelefsky, 2013, Brachytherapy.

Techniques for Reducing Toxicity After SBRT

M. Zelefsky, D. Gorovets, M. Kollmeier, 2018, Stereotactic Radiosurgery for Prostate Cancer.

Intraoperative Radiation Therapy for Breast Cancer: Technical Notes

A. Luini, M. Zelefsky, U. Veronesi, 2003, The breast journal.

Radiotherapy After Surgical Resection for Head and Neck Mucosal Melanoma

J. Shah, M. Zelefsky, J. Wolchok, 2009, American journal of clinical oncology.

Preliminary results of Phase I/II study of high‐dose‐rate intraoperative radiation therapy for pediatric tumors

M. Zelefsky, L. Harrison, M. LaQuaglia, 1996, Journal of surgical oncology.

Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk.

M. Zelefsky, M. Brennan, K. Alektiar, 2000, International journal of radiation oncology, biology, physics.

Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins.

E. Strong, J. Shah, M. Zelefsky, 1993, International journal of radiation oncology, biology, physics.

Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy

M. Zelefsky, N. Lee, B. Mychalczak, 2014, Head & neck.

Association between Site-of-Care and the Cost and Modality of Radiotherapy for Prostate Cancer: Analysis of Medicare Beneficiaries from 2015 to 2017

Aaron P. Mitchell, M. Zelefsky, E. Gillespie, 2021, Cancer investigation.

Quantifying clinical severity of physics errors in high-dose rate prostate brachytherapy using simulations.

G. Cohen, M. Zelefsky, L. Dauer, 2021, Brachytherapy.

Long-term results of ileocecal continent urinary diversion in patients treated with or without previous pelvic irradiation

M. Zelefsky, R. Hohenfellner, R. Wammack, 2003 .

The indications for elective treatment of the neck in cancer of the major salivary glands

R. Spiro, E. Strong, J. Shah, 1992, Cancer.

About «Second malignancy (SM) in prostate cancer patients treated with SBRT and other contemporary radiation techniques» by Edward Christopher Deeand colleagues.

M. Zelefsky, J. Cosset, P. Blanchard, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation.

M. Zelefsky, B. Mychalczak, H. Schöder, 2022, Urology.

Urinary Outcomes for Men With High Baseline International Prostate Symptom Scores Treated With Prostate SBRT

M. Zelefsky, D. Goldman, S. McBride, 2020, Advances in radiation oncology.

Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy.

K. Rosenzweig, Y. Yamada, M. Zelefsky, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Second malignancy risk in prostate cancer and radiotherapy.

M. Zelefsky, A. Taggar, T. Charas, 2017, Future oncology.

Reply from Authors re: Alberto Bossi, Gert De Meerleer, Piet Ost. Intensity-Modulated Radiotherapy: The Gold Standard for Postprostatectomy Irradiation? Eur Urol 2011;60:1149–50

M. Zelefsky, A. Goenka, 2011 .

16 : Long-Term Distant Metastases-Free Survival and Cause-Specific Survival Outcomes After High Dose Conformal Radiotherapy for Clinically Localized Prostate Cancer

Y. Yamada, M. Zelefsky, H. Amols, 2006 .

Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable‐risk localized prostate cancer

M. Zelefsky, E. Small, J. Bogart, 2008, Cancer.

Improving outcomes in high-risk prostate cancer with radiotherapy.

M. Zelefsky, W. Polkinghorn, 2013, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Clinical Nodal Stage Is an Independently Significant Predictor of Distant Failure in Patients With Squamous Cell Carcinoma of the Larynx

J. Shah, M. Zelefsky, D. Kraus, 2003, Annals of surgery.

Conclusions: Perspectives on the Role of SBRT in the Management of Localized Prostate Cancer

M. Zelefsky, 2018, Stereotactic Radiosurgery for Prostate Cancer.

Evaluation of external-beam radiotherapy treatment plans incorporating treatment uncertainties: a new and essential method for dose-painting IMRT plans for prostate cancer

C. Ling, A. Hertanto, M. Zelefsky, 2002 .

Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland

J. Shah, M. Zelefsky, D. Gomez, 2009, Cancer.

High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.

M. Zelefsky, J. Guillem, L. Saltz, 2000, International journal of radiation oncology, biology, physics.

Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma

M. Zelefsky, W. Shi, K. Goodman, 2015, Annals of Surgical Oncology.

Intraoperative high-dose-rate brachytherapy using dose painting technique: evaluation of safety and preliminary clinical outcomes.

M. Zaider, G. Cohen, M. Zelefsky, 2013, Brachytherapy.

Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra.

M. Zelefsky, G. Dalbagni, H. Herr, 2001, The Journal of urology.

Sildenafil Citrate and Risk of Biochemical Recurrence in Prostate Cancer Patients Treated With Radiation Therapy: Post-Hoc Analysis of a Randomized Controlled Trial.

M. Zelefsky, E. Schofield, S. McBride, 2021, The journal of sexual medicine.

Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy.

M. Zelefsky, A. Harrison, 1997, Urology.

Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control

E. Yorke, M. Zelefsky, J. Deasy, 2018, Radiation oncology.

136 : Evaluation of Doses on a 2D Map of the Rectal Wall for Patients Treated With IMRT for Prostate Cancer

M. Zelefsky, R. Munbodh, A. Jackson, 2006 .

Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer.

G. Cohen, M. Zelefsky, A. Damato, 2021, Brachytherapy.

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial

M. Zelefsky, 2006 .

Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study

M. Zelefsky, 2006 .

76 Impact of radiation dose on achieving nadir PSA levels after 3-dimensional conformal radiotherapy for patients with localized prostate cancer

M. Zelefsky, S. Leibel, Z. Fuks, 1996 .

Anatomic Patterns of Recurrence Following Biochemical Relapse in the Dose-Escalation Era for Prostate Patients Undergoing External Beam Radiotherapy

Y. Yamada, M. Zelefsky, D. Spratt, 2016 .

Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy.

Y. Yamada, M. Zelefsky, D. Spratt, 2013, International journal of radiation oncology, biology, physics.

Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: a 10-year experience.

Suzanne L Wolden, David D'Souza, M. Zelefsky, 2003, Brachytherapy.

Acute morbidity and PSA response in patients with carcinoma of the prostate treated with three dimensional conformal radiation therapy

R. Mohan, M. Zelefsky, Y. Lo, 1992 .

Androgen receptor signaling regulates DNA repair in prostate cancers.

H. Hieronymus, P. Scardino, M. Zelefsky, 2013, Cancer discovery.

Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.

M. Zelefsky, H. Vargas, D. Spratt, 2017, European urology.

Radium-223 outcomes after multiple lines of metastatic castration-resistant prostate cancer therapy in clinical practice: implication of pre-treatment spinal epidural disease

M. Zelefsky, M. Morris, D. Spratt, 2016, Prostate Cancer and Prostatic Disease.

Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil

M. Zelefsky, J. Dunst, C. Rödel, 2003 .

Results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcoma

M. Zelefsky, L. Harrison, M. Brennan, 1992 .

Real-Time Intraoperative CT Assessment of Quality of Permanent Interstitial Seed Implantation for Prostate Cancer

M. Zaider, G. Cohen, M. Zelefsky, 2014 .

The current state of brachytherapy nomograms for patients with clinically localized prostate cancer

M. Kattan, M. Zelefsky, C. Nguyen, 2009, Cancer.

A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy.

Y. Yamada, M. Zelefsky, D. Spratt, 2013, European urology.

3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center.

C. Ling, R. Mohan, M. Zelefsky, 1996, Frontiers of radiation therapy and oncology.

PSA response after transperineal I-125 prostate implantation

J. Roy, K. Wallner, M. Zelefsky, 1993 .

Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT.

Y. Yamada, M. Zaider, G. Cohen, 2008, Brachytherapy.

Three-dimensional conformal radiotherapy and dose escalation: where do we stand?

G J Kutcher, S A Leibel, Z Fuks, 1998, Seminars in radiation oncology.

The biochemical and clinical significance of the post-treatment PSA bounce for prostate cancer patients treated with external beam radiation therapy alone: A multi-institutional pooled analysis

D. Kuban, M. Zelefsky, A. Zietman, 2004 .

Platinum Priority – Collaborative Review – Prostate Cancer Early Salvage Radiotherapy following Radical Prostatectomy

P. Carroll, M. Zelefsky, M. Roach, 2022 .

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Richard K Valicenti, Jeff M Michalski, Michael W Kattan, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tolerance of tissue transfers to adjuvant radiation therapy in primary soft tissue sarcoma of the extremity.

M. Zelefsky, M. Brennan, P. Cordiero, 2003, International journal of radiation oncology, biology, physics.

Short-term freedom from disease progression after I-125 prostate implantation.

J. Roy, K. Wallner, M. Zelefsky, 1994, International journal of radiation oncology, biology, physics.

Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy.

M. Zelefsky, J. Deasy, G. Steineck, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prostate, Seminal Vesicle, Penis, and Urethra

M. Zelefsky, B. Cox, 2014 .

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.

Michael J. Zelefsky, Yoshiya Yamada, C. Ling, 2002, International journal of radiation oncology, biology, physics.

A Phase II Trial of Bryostatin-1 in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

W. Gerald, J. Shah, M. Zelefsky, 2002, Investigational New Drugs.

Fluoroscopically guided interventional procedures: a review of radiation effects on patients' skin and hair.

Stephen Balter, Donald L. Miller, John W Hopewell, 2010, Radiology.

Salvage Laryngectomy for Unsuccessful Larynx Preservation Therapy

R. Spiro, E. Strong, J. Shah, 1995, The Annals of otology, rhinology, and laryngology.

TALK score: Development and validation of a prognostic model for predicting larynx preservation outcome

V. Seshan, J. Shah, M. Zelefsky, 2012, The Laryngoscope.

Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation.

R Mohan, T LoSasso, G J Kutcher, 1996, International journal of radiation oncology, biology, physics.

Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer.

Y. Yamada, M. Zelefsky, L. Dauer, 2012, International journal of radiation oncology, biology, physics.

Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy.

M. Zelefsky, Z. Fuks, J. Gaynor, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue

E. Strong, M. Zelefsky, H. Thaler, 1997, Head & neck.

Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer.

E. Yorke, M. Zaider, G. Cohen, 2005, International journal of radiation oncology, biology, physics.

American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.

Wayne M Butler, Louis Potters, Anthony L Zietman, 2012, Brachytherapy.

Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer

P. Scardino, J. Eastham, M. Zelefsky, 2010, Clinical Cancer Research.

Genomic characterization of response to chemoradiation in urothelial bladder cancer

M. Berger, M. Zelefsky, I. Ostrovnaya, 2016, Cancer.

High-risk prostate cancer: from definition to contemporary management.

M. Zelefsky, F. Montorsi, S. Boorjian, 2012, European urology.

Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI.

Amita Shukla-Dave, Darko Pucar, Hedvig Hricak, 2010, International journal of radiation oncology, biology, physics.

Prostate Cancer: Radiation therapy

M. Zelefsky, M. Kollmeier, 2008 .

Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.

M. Zelefsky, D. Spratt, Z. Zumsteg, 2013, European urology.

Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.

M. Kattan, P. Scardino, M. Zelefsky, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.

M. Zelefsky, J. Reis-Filho, B. Weigelt, 2020, Journal of the National Cancer Institute.

Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent.

J. Shah, E. Venkatraman, M. Zelefsky, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.

J. Shah, M. Zelefsky, D. Kraus, 2011, International journal of radiation oncology, biology, physics.

Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.

M. Zelefsky, S. Leibel, Z. Fuks, 2005, International journal of radiation oncology, biology, physics.

Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis.

D. Kuban, M. Zelefsky, A. Zietman, 2005, The Journal of urology.

Intensity-modulated radiotherapy.

Andrew Jackson, Kenneth E Rosenzweig, C Clifton Ling, 2002, Cancer journal.

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

Brady J. McKee, E. Venkatraman, M. Zelefsky, 2002, International journal of radiation oncology, biology, physics.

Adjuvant Radiation for Stage II-B Soft Tissue Sarcoma of the Extremity

M. Zelefsky, D. Leung, M. Brennan, 2002 .

Adjuvant brachytherapy for primary high-grade soft tissue sarcoma of the extremity

M. Zelefsky, J. Healey, M. Brennan, 2002, Annals of Surgical Oncology.

30 – Cancer of the Hypopharynx

M. Zelefsky, N. Lee, A. Rimner, 2010 .

Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer.

K. Wallner, M. Zelefsky, S. Leibel, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement.

M. Zelefsky, S. Leibel, W. Whitmore, 1994, International journal of radiation oncology, biology, physics.

Predictors of castration‐resistant prostate cancer after dose‐escalated external beam radiotherapy

M. Zelefsky, D. Spratt, Z. Zumsteg, 2015, The Prostate.

Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues.

M. Zelefsky, V. Reuter, S. Leibel, 1999, The American journal of surgical pathology.

The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy.

Y. Yamada, M. Zelefsky, D. Spratt, 2015, European urology.

American Cancer Society prostate cancer survivorship care guidelines

T. Skolarus, M. Zelefsky, D. Brooks, 2014, CA: a cancer journal for clinicians.

Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy.

Y. Yamada, M. Zelefsky, W. Shi, 2011, International journal of radiation oncology, biology, physics.

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

E. B. Butler, M. Kattan, C. Roehrborn, 2004, JAMA.

Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer.

E. Venkatraman, M. Zelefsky, H. Scher, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy.

G. Cohen, M. Zelefsky, A. Zietman, 2011, Brachytherapy.

Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.

P. Scardino, J. Eastham, M. Zelefsky, 2012, International journal of radiation oncology, biology, physics.

Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer.

M. Zelefsky, W. Shi, X. Pei, 2014, Urology.

Conventional treatments of localized prostate cancer.

P. Carroll, M. Zelefsky, C. Higano, 2008, Urology.

Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes.

Yoshiya Yamada, Y. Yamada, M. Zelefsky, 2008, International journal of radiation oncology, biology, physics.

Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer.

Y. Yamada, M. Zelefsky, Alison M. Shippy, 2008, European urology.

Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes.

Yoshiya Yamada, Y. Yamada, M. Zelefsky, 2008, International journal of radiation oncology, biology, physics.

Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes.

Michael W Kattan, Mack Roach, Louis Potters, 2007, International journal of radiation oncology, biology, physics.

A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer.

Y. Yamada, G. Cohen, M. Zelefsky, 2013, Brachytherapy.

Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?

M. Zelefsky, Z. Zumsteg, 2012, The Lancet. Oncology.

Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.

E. Venkatraman, M. Zelefsky, S. Leibel, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.

H. Hricak, P. Scardino, J. Eastham, 2007, International journal of radiation oncology, biology, physics.

Locally advanced prostate cancer: a population‐based study of treatment patterns

Coral L. Atoria, W. Lowrance, E. Elkin, 2012, BJU international.

Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience.

M. Zelefsky, D. Kraus, D. Pfister, 2006, International journal of radiation oncology, biology, physics.

Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data.

C C Ling, A Jackson, W Schlegel, 2001, International journal of radiation oncology, biology, physics.

Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy.

G. Cohen, M. Zelefsky, D. Kraus, 2010, International journal of radiation oncology, biology, physics.

Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.

M. Zelefsky, C. Marion, S. Leibel, 2003, The Journal of urology.

The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma

Brady J. McKee, E. Venkatraman, M. Zelefsky, 2002, Cancer.

Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma.

K. Rosenzweig, M. Zelefsky, D. Kraus, 2001, International journal of radiation oncology, biology, physics.

Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.

K. Rosenzweig, J. Shah, M. Zelefsky, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity.

M. Zelefsky, M. Brennan, J. Woodruff, 2000, International journal of radiation oncology, biology, physics.

Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer.

M. Zelefsky, H. Scher, S. Leibel, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer.

M. Zelefsky, D. Kraus, D. Pfister, 2000, International journal of radiation oncology, biology, physics.

Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection.

M. Zelefsky, D. Lombardi, S. Leibel, 2000, International journal of radiation oncology, biology, physics.

Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer.

M. Zelefsky, S. Leibel, Z. Fuks, 1999, International journal of radiation oncology, biology, physics.

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.

K. Wallner, C. Ling, M. Zelefsky, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma

M. Zelefsky, C. Burman, S. Leibel, 1999, Cancer.

Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic Cancer

Michael J. Zelefsky, Kent Wallner, C. Clifton Ling, 1999 .

Comparison o f t he 5 -Year O utcome a nd M orbidity of T hree-Dimensiona l C onformal R adiotherapy Versus T ransperineal P ermanent I odine-125 I mplantation for E arly-Stage P rostatic C ancer

K. Wallner, C. Ling, M. Zelefsky, 1999 .

Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy.

C. Ling, M. Zelefsky, C. Burman, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER

William R. Fair, Gerald J. Kutcher, Michael J. Zelefsky, 1998 .

Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer.

M. Zelefsky, J. Eid, 1998, International journal of radiation oncology, biology, physics.

Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy.

M. Zelefsky, S. Leibel, S. Kelsen, 1997, International journal of radiation oncology, biology, physics.

Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study.

M. Zelefsky, C. Burman, S. Leibel, 1994, The Journal of urology.

Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study.

R Mohan, G J Kutcher, S A Leibel, 1994, International journal of radiation oncology, biology, physics.

American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancer.

J. Blasko, M. Zelefsky, G. Merrick, 2017, Brachytherapy.

Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.

P. Scardino, J. Eastham, M. Zelefsky, 2011, European urology.

Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008

Clifton D Fuller, Charles R. Thomas, Laurence H Baker, 2009, Clinical Cancer Research.

Continuous monitoring and intrafraction target position correction during treatment improves target coverage for patients undergoing SBRT prostate therapy.

Michael J. Zelefsky, D. Michael Lovelock, M. Zelefsky, 2015, International journal of radiation oncology, biology, physics.

Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.

Louis Potters, Anthony L Zietman, J. Blasko, 2007, International journal of radiation oncology, biology, physics.

Comparison of biochemical failure definitions for permanent prostate brachytherapy.

J. Blasko, D. Kuban, L. Potters, 2005, International journal of radiation oncology, biology, physics.

A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesothelioma.

K. Rosenzweig, V. Rusch, M. Zelefsky, 2005, Brachytherapy.

20-year experience with intraoperative high-dose-rate brachytherapy for pediatric sarcoma: outcomes, toxicity, and practice recommendations.

Suzanne L Wolden, Michael R Folkert, M. Zelefsky, 2014, International journal of radiation oncology, biology, physics.

Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma.

J. Mechalakos, Y. Yamada, M. Zelefsky, 2012, International journal of radiation oncology, biology, physics.

A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.

Suzanne L Wolden, James Mechalakos, Ashwatha Narayana, 2006, International journal of radiation oncology, biology, physics.

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.

Yoshiya Yamada, Y. Yamada, M. Zelefsky, 2006, The Journal of urology.

Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.

D. Kuban, M. Zelefsky, A. Zietman, 2003, International journal of radiation oncology, biology, physics.

How to select the optimal therapy for early-stage prostate cancer.

M. Zelefsky, M. Kollmeier, Marisa A Kollmeier, 2012, Critical reviews in oncology/hematology.

Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx.

J. Shah, M. Zelefsky, D. Kraus, 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions.

Y. Yamada, E. Venkatraman, M. Zelefsky, 2008, International journal of radiation oncology, biology, physics.

An international Delphi consensus for pelvic Stereotactic Ablative Radiotherapy re-irradiation.

M. Zelefsky, D. Spratt, F. Alongi, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Salvage re-irradiation for recurrent head and neck cancer.

J. Mechalakos, J. Shah, E. Venkatraman, 2007, International journal of radiation oncology, biology, physics.

The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.

J. Mechalakos, Y. Yamada, M. Zelefsky, 2017, Neurosurgical focus.

Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens.

M. Zelefsky, H. Scher, J. Forman, 1989, International journal of radiation oncology, biology, physics.

Phenotype-Oriented Ablation of Oligometastatic Cancer with Single Dose Radiation Therapy.

M. Zelefsky, Z. Fuks, R. Kolesnick, 2019, International journal of radiation oncology, biology, physics.

A prospective phase ii trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck

R. Spiro, E. Strong, J. Shah, 1998, Head & neck.

Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience.

K. Rosenzweig, J. Shah, M. Zelefsky, 2007, International journal of radiation oncology, biology, physics.

Postoperative intensity‐modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: Technique, early outcomes, and toxicity

J. Mechalakos, M. Zelefsky, D. Kraus, 2008, Head & neck.

Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.

J. Shah, M. Zelefsky, D. Gomez, 2008, International journal of radiation oncology, biology, physics.

44 – Cancer of the Bladder

M. Zelefsky, E. Small, J. Rosenberg, 2010 .

Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.

M. Zelefsky, N. Lee, B. Mychalczak, 2015, Oral oncology.

Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma.

E. Strong, J. Shah, M. Zelefsky, 1997, International journal of radiation oncology, biology, physics.

Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy.

H. Hricak, M. Zelefsky, O. Akin, 2012, International journal of radiation oncology, biology, physics.

Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

H. Hricak, J. Eastham, M. Zelefsky, 2019, European urology oncology.

SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes.

M. Zelefsky, N. Tyagi, Zhigang Zhang, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI

Michael J. Zelefsky, Yousef Mazaheri, Oguz Akin, 2015, European Radiology.

Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.

P. Scardino, J. Eastham, M. Zelefsky, 2021, Urologic oncology.

Imaging and Anatomic Considerations for Prostate and Pelvic Organs Contouring

M. Zelefsky, T. Charas, Alberto Vargas, 2018, Stereotactic Radiosurgery for Prostate Cancer.

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

D. Kuban, M. Zelefsky, A. Zietman, 2003, International journal of radiation oncology, biology, physics.

Favourable long‐term outcomes with brachytherapy‐based regimens in men ≤60 years with clinically localized prostate cancer

Y. Yamada, M. Zaider, G. Cohen, 2013, BJU international.

Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer.

Marco Zaider, Xin Pei, Josh Yamada, 2010, Urology.

Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury

Evis Sala, Howard J. Halpern, Michael J. Zelefsky, 2019, The Journal of clinical investigation.

Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer.

P. Scardino, J. Eastham, M. Zelefsky, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

C. Ling, M. Zelefsky, P. Walsh, 1999, International journal of radiation oncology, biology, physics.

Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.

J. Shah, M. Zelefsky, D. Kraus, 2012, International journal of radiation oncology, biology, physics.

Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer‐specific mortality and treatment‐related toxicity

M. Zelefsky, X. Pei, S. McBride, 2015, BJU international.

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.

Suzanne L Wolden, Eric Lis, J. Shah, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical implementation of deep learning contour autosegmentation for prostate radiotherapy.

M. Zelefsky, J. Deasy, D. Gorovets, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Deep learning-based auto-segmentation of targets and organs-at-risk for magnetic resonance imaging only planning of prostate radiotherapy

Harini Veeraraghavan, Joseph O. Deasy, Michael J. Zelefsky, 2019, Physics and imaging in radiation oncology.

Deep learning based dominant index lesion segmentation for mr-guided radiation therapy of prostate cancer.

M. Zelefsky, H. Veeraraghavan, A. Wibmer, 2023, Medical physics.

Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.

M. Zelefsky, D. Kraus, N. Lee, 2011, International journal of radiation oncology, biology, physics.

Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?

Chaya S Moskowitz, Oguz Akin, Hedvig Hricak, 2013, Radiology.

Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer.

E. Venkatraman, M. Zelefsky, S. Leibel, 2002, International journal of radiation oncology, biology, physics.

Spatial and Anatomical Indicators of Rectal Toxicity in IMRT of Prostate Cancer

M. Zelefsky, R. Munbodh, A. Jackson, 2007 .

Phase III Multi-Center, Prospective Randomized Trial Comparing High Dose Single Fraction Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Human Cancer

Y. Yamada, M. Zelefsky, W. Shi, 2018, International Journal of Radiation Oncology*Biology*Physics.

The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.

D. Kuban, M. Zelefsky, A. Zietman, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer.

Michael J. Zelefsky, Xin Pei, Josh Yamada, 2013, International journal of radiation oncology, biology, physics.

Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer.

Y. Yamada, M. Zaider, G. Cohen, 2011, Urology.

Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost.

G. Cohen, M. Zelefsky, A. Damato, 2022, Brachytherapy.

Unification of favourable intermediate‐, unfavourable intermediate‐, and very high‐risk stratification criteria for prostate cancer

M. Zelefsky, H. Sandler, D. Spratt, 2017, BJU international.

Pathophysiology of Erectile Dysfunction Following Radiation Therapy

M. Zelefsky, V. Croog, 2009 .

Definitions of biochemical failure that best predict clinical failure in prostate cancer patients treated with external beam radiation alone- a multi-institutional pooled analysis

D. Kuban, M. Zelefsky, A. Zietman, 2003 .

Biochemical and clinical significance of the posttreatment prostate‐specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone

D. Kuban, M. Zelefsky, A. Zietman, 2006, Cancer.

Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation.

E. Strong, J. Shah, M. Zelefsky, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of high‐dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate‐risk prostate cancer

Y. Yamada, G. Cohen, M. Zelefsky, 2014, BJU international.

Intensity-modulated radiation therapy for prostate cancer.

M. Zelefsky, S. Leibel, Z. Fuks, 2002, Seminars in radiation oncology.

A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans.

R Mohan, G J Kutcher, S A Leibel, 1996, International journal of radiation oncology, biology, physics.

Statin use not associated with improved outcomes in patients treated with brachytherapy for prostate cancer.

Y. Yamada, G. Cohen, M. Zelefsky, 2015, Brachytherapy.

Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer.

G J Kutcher, S A Leibel, M. Zelefsky, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Adam P Dicker, Richard Stock, Steven Frank, 2012, BJU international.

Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer.

Y. Yamada, M. Zaider, G. Cohen, 2013, Brachytherapy.

Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer.

Victor E Reuter, P. Scardino, M. Zelefsky, 2008, The Journal of urology.

Magnetic resonance imaging-based salvage brachytherapy: Moving toward a focal paradigm.

M. Zelefsky, S. McBride, M. Kollmeier, 2017, Brachytherapy.

An Analysis of Prognostic Factors for Local Control of Malignant Spine Tumors Treated with Spine Radiosurgery

Y. Yamada, M. Zelefsky, M. Bilsky, 2011 .

Physician visits prior to treatment for clinically localized prostate cancer.

C. Begg, E. Elkin, T. Jang, 2010, Archives of internal medicine.

American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review.

P. Grimm, M. Zelefsky, G. Merrick, 2017, Brachytherapy.

Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.

Michael J. Zelefsky, Thomas W. Feeley, Peter F. Orio, 2015, Brachytherapy.

Patterns of relapse and second malignancy after adjuvant external beam radiation therapy for stage I-II seminoma.

M. Zelefsky, M. Folkert, D. Feldman, 2017 .

Larynx Preservation with Combined Chemotherapy and Radiation Therapy in Advanced Hypopharynx Cancer

R. Spiro, E. Strong, J. Shah, 1994, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Secondary cancers after intensity‐modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause‐specific survival outcomes according to the initial treatment intervention

M. Zelefsky, B. Cox, X. Pei, 2012, BJU international.

Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer.

M. Zelefsky, W. Whitmore, M J Zelefsky, 1997, The Journal of urology.

Endorectal MR imaging before salvage prostatectomy: tumor localization and staging.

Evis Sala, Chaya S Moskowitz, Oguz Akin, 2006, Radiology.

New treatments for localized prostate cancer.

Hedvig Hricak, P. Carroll, H. Hricak, 2008, Urology.

Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.

D. Kuban, M. Zelefsky, A. Zietman, 2004, International journal of radiation oncology, biology, physics.

Low dose rate brachytherapy combined with ultra-hypofractionated radiation therapy for clinically localized, intermediate-risk prostate cancer: Results from a prospective trial.

G. Cohen, M. Zelefsky, A. Damato, 2020, International journal of radiation oncology, biology, physics.

Long-Term Implications of a Positive Posttreatment Biopsy in Patients Treated with External Beam Radiotherapy for Clinically Localized Prostate Cancer

M. Zelefsky, V. Reuter, Z. Fuks, 2019, The Journal of urology.

The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate.

R Mohan, G J Kutcher, C C Ling, 1994, Seminars in oncology.

Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality.

V. Seshan, Y. Yamada, M. Zelefsky, 2009, International journal of radiation oncology, biology, physics.

PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.

D. Kuban, M. Zelefsky, A. Zietman, 2004, International journal of radiation oncology, biology, physics.

External beam radiation therapy for small cell carcinoma of the urinary bladder.

M. Zelefsky, G. Dalbagni, M. Kollmeier, 2015, Practical radiation oncology.

A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development.

P. Scardino, M. Zelefsky, M. Kattan, 2005, Clinical prostate cancer.

High-dose rate intraoperative radiation therapy for pediatric solid tumors.

M. Zelefsky, T. Merchant, L. Harrison, 1998, Medical and pediatric oncology.

Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer.

Andrew Jackson, C Clifton Ling, Chen-Shou Chui, 2003, Seminars in oncology.

High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neck.

Y. Yamada, M. Zelefsky, N. Lee, 2016, Oral oncology.

Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer.

C. Ling, W. Schlegel, E. Venkatraman, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma.

C. Ling, M. Zelefsky, S. Leibel, 1995, The cancer journal from Scientific American.

Radiation therapy for de novo anorectal cancer in patients with a history of prostate radiation therapy

M. Zelefsky, C. Crane, Zhigang Zhang, 2022, Frontiers in Oncology.

Principal component, Varimax rotation and cost analysis of volume effects in rectal bleeding in patients treated with 3D-CRT for prostate cancer

M. Zelefsky, A. Jackson, M. Skwarchuk, 2006, Physics in Medicine and Biology.

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy.

M. Zelefsky, C. Burman, S. Leibel, 1994, International journal of radiation oncology, biology, physics.

J Roy, Z Fuks, J. Roy, 1994, International journal of radiation oncology, biology, physics.

Original Articles LONG-TERM RESULTS OF RETROPUBIC PERMANENT I2"IODINE IMPLANTATION OF THE PROSTATE FOR CLINICALLY LOCALIZED PROSTATIC CANCER

M. Zelefsky, W. Whitmore, 1997 .

Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.

M. Kattan, L. Potters, M. Zelefsky, 2009, International journal of radiation oncology, biology, physics.

Prostate SBRT with intra-fraction motion management using a novel LINAC-based MV-kV imaging method.

M. Zelefsky, L. Happersett, B. Ravindranath, 2020, Practical radiation oncology.

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity

M. Zelefsky, 2005 .

Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate.

M. Zelefsky, S. Leibel, A. McKee, 1999, Urology.

Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients.

M. Zelefsky, W. Shi, X. Pei, 2018, International journal of radiation oncology, biology, physics.

ePoster SessionsDose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data

M. Zelefsky, X. Pei, S. McBride, 2017 .

Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.

G. Cohen, M. Zelefsky, A. Damato, 2017, Brachytherapy.

Impact of daily soft‐tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT

J. Mechalakos, M. Zelefsky, M. Hunt, 2019, Journal of applied clinical medical physics.

Developing a MLC modifier program to improve fiducial detection for MV/kV imaging during hypofractionated prostate volumetric modulated arc therapy

J. Mechalakos, G. Mageras, M. Zelefsky, 2019, Journal of applied clinical medical physics.

Robust plan optimization for electromagnetic transponder guided hypo-fractionated prostate treatment using volumetric modulated arc therapy

Jie Yang, Pengpeng Zhang, Margie Hunt, 2013, Physics in medicine and biology.

Computerized design of target margins for treatment uncertainties in conformal radiotherapy.

M van Herk, G J Kutcher, C C Ling, 1999, International journal of radiation oncology, biology, physics.

Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.

J. Mechalakos, J. Shah, M. Zelefsky, 2008, International journal of radiation oncology, biology, physics.

Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy.

Y. Yamada, M. Zaider, G. Cohen, 2016, Brachytherapy.

Management of Unresectable Malignant Tumors at the Skull Base Using Concomitant Chemotherapy and Radiotherapy with Accelerated Fractionation

E. Strong, J. Shah, M. Zelefsky, 1994, Skull base surgery.

Adjuvant radiation for stage II-B soft tissue sarcoma of the extremity.

M. Zelefsky, D. Leung, M. Brennan, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of postradiotherapy PSA patterns and correlation with 10-year disease free survival outcomes for prostate cancer.

E. Venkatraman, M. Zelefsky, L. Ben-Porat, 2006, International journal of radiation oncology, biology, physics.

Long-term Regional Control in the Observed Neck following Definitive Chemoradiation for Node-positive Oropharyngeal Squamous Cell Cancer

M. Zelefsky, D. Kraus, N. Lee, 2011 .

Pathogenic Mutations in ATM Predict for Enhanced Local Control in Prostate Cancers Treated with Radiation Thearpy

M. Zelefsky, J. Reis-Filho, T. Chan, 2018, International Journal of Radiation Oncology*Biology*Physics.

Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.

M. Zelefsky, H. Scher, S. Leibel, 2004, Urology.

Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning.

Y. Yamada, G. Cohen, M. Zelefsky, 2014, International journal of radiation oncology, biology, physics.

Improved survival with surgery in prostate cancer patients without medical comorbidity: a self-fulfilling prophecy?

M. Zelefsky, Z. Zumsteg, 2013, European urology.

The Anderson nomograms for permanent interstitial prostate implants: a briefing for practitioners.

M. Zaider, G. Cohen, M. Zelefsky, 2002, International journal of radiation oncology, biology, physics.

Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation.

J Roy, Z Fuks, J. Roy, 1994, International journal of radiation oncology, biology, physics.

Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study.

I. Hsu, L. Potters, M. Zelefsky, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups.

D. Kuban, M. Zelefsky, A. Zietman, 2006, International Journal of Radiation Oncology, Biology, Physics.

Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?

D. Kuban, M. Zelefsky, A. Zietman, 2003, International journal of radiation oncology, biology, physics.

Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis.

Benjamin Movsas, Jean Owen, M. Zelefsky, 2007, International journal of radiation oncology, biology, physics.

PSA bounce versus biochemical failure following prostate brachytherapy

M. Zelefsky, 2006, Nature Clinical Practice Urology.

Locally advanced prostatic cancer: long-term toxicity outcome after three-dimensional conformal radiation therapy--a dose-escalation study.

G J Kutcher, C C Ling, S A Leibel, 1998, Radiology.

Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement.

L. Potters, M. Zelefsky, W. Butler, 2021, Brachytherapy.

Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.

Andrew Jackson, Margie Hunt, Pengpeng Zhang, 2010, International journal of radiation oncology, biology, physics.

Location and number of positive surgical margins as prognostic factors of biochemical recurrence after salvage radiation therapy after radical prostatectomy

B. Guillonneau, P. Scardino, J. Eastham, 2010, BJU international.

Clinical workflow for MR-only simulation and planning in prostate

J. Mechalakos, M. Zelefsky, M. Hunt, 2017, Radiation oncology.

A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.

D. Kuban, C. Roehrborn, P. Scardino, 2005, Urology.

Results from the Quality Research in Radiation Oncology (QRRO) Survey Evaluating Adherence to Quality Measures for Prostate Cancer Radiotherapy

M. Zelefsky, A. Zietman, W. Lee, 2010 .

The 1999 patterns of care study of radiotherapy in localized prostate carcinoma

M. Zelefsky, W. Lee, W Robert Lee, 2003, Cancer.

Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.

M. Kattan, P. Scardino, M. Zelefsky, 2007, Urology.

The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy.

G J Kutcher, S A Leibel, Z Fuks, 1997, International journal of radiation oncology, biology, physics.

High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer.

J. Shah, M. Zaider, G. Cohen, 2010, International Journal of Radiation Oncology, Biology, Physics.

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer

Michael J. Zelefsky, M. Zelefsky, 2004 .

High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer.

G. Cohen, M. Zelefsky, N. Lee, 2012, Brachytherapy.

Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.

Y. Yamada, G. Cohen, M. Zelefsky, 2017, Brachytherapy.

High dose per fraction, short course irradiation for malignant melanoma of the head and neck

M. Zelefsky, A. Raben, L. Harrison, 1993 .

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous (PS)/clear cell (CC) histologies and endometrioid FIGO grade 3

Brady J. McKee, M. Zelefsky, R. Barakat, 2001 .

MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer.

H. Hricak, J. Eastham, M. Zelefsky, 2013, European journal of radiology.

The 1999 patterns of care survey of radiation therapy in localized prostate cancer—a comprehensive survey of prostate brachytherapy in the United States

M. Zelefsky, W. Lee, J. Owen, 2003 .

Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control

E. Yorke, M. Zelefsky, J. Deasy, 2018, Radiation oncology.

Dosimetric consequence of three setup correction schemes for external-beam radiotherapy of prostate cancer

C. Ling, M. Zelefsky, A. Jackson, 2002 .

Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer.

Marco Zaider, Yoshiya Yamada, Sudershan Bhatia, 2006, Brachytherapy.

Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.

M Zaider, J A Koutcher, H. Hricak, 2000, Cancer journal.

The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines.

M. Zelefsky, M. Keyes, É. Vigneault, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensity-modulated radiation therapy for head and neck cancer of unknown primary.

J. Shah, M. Zelefsky, D. Kraus, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reply to D.A. Hamstra et al and A.P. Sandhu

P. Scardino, J. Eastham, M. Zelefsky, 2010 .

Short-term results of computerized tomographic-based transperineal iodine-125 prostate implantation

J. Roy, K. Wallner, M. Zelefsky, 1993 .

Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy.

D. Kuban, M. Zelefsky, C. Catton, 2005, International journal of radiation oncology, biology, physics.

Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure.

D. Kuban, M. Zelefsky, A. Zietman, 2006, Urology.

Radiotherapy in early stage invasive breast cancer: current tendencies

M. Zelefsky, R. Martínez-Monge, K. Shin, 2005, Breast Cancer Research.

Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable.

M. Kattan, L. Potters, M. Zelefsky, 2010, International journal of radiation oncology, biology, physics.

Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.

M. Zelefsky, R. Hannan, Y. Lotan, 2017, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Stereotactic Radiosurgery for Prostate Cancer

M. Zelefsky, 2019, Springer International Publishing.

Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience.

Y. Yamada, M. Zaider, G. Cohen, 2012, Brachytherapy.

Combined Surgery and Radiation Therapy for Squamous Cell Carcinoma of the Hypopharynx

J. Shah, M. Zelefsky, D. Kraus, 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

To Radiate or Not to Radiate-The Challenges of Pelvic Reirradiation.

M. Zelefsky, S. Kamran, C. Lawton, 2020, Seminars in radiation oncology.

21 Long term results of primary radiation therapy for squamous cancer of the base of tongue

E. Strong, J. Shah, M. Zelefsky, 1996 .

Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.

Marco Zaider, Yoshiya Yamada, Y. Yamada, 2008, Brachytherapy.

Tumor Control Outcome and Tolerance of Permanent Interstitial Implantation for Patients with Clinically Localized Prostate Cancer

M. Zelefsky, 2005 .

Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy.

Y. Yamada, M. Zelefsky, K. Peck, 2017, Neurosurgical focus.

Three-dimensional conformal brachytherapy for prostate cancer

M. Zelefsky, 2004 .

Radiotherapy of Prostate Cancer

Michael J. Zelefsky, Carlo Greco, M. Zelefsky, 2000 .

Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiation Therapy and Association of Metric Score With Rectal Toxicity Outcomes

M. Zelefsky, R. Hannan, M. Folkert, 2023, Advances in radiation oncology.

Quantitative longitudinal mapping of radiation-treated prostate cancer using MR fingerprinting with radial acquisition and subspace reconstruction.

M. Zelefsky, R. Otazo, M. Doneva, 2023, Magnetic resonance imaging.

Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy.

G. Cohen, M. Zelefsky, L. Dauer, 2016, Brachytherapy.

Long‐term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma

M. Zelefsky, L. Harrison, J. Armstrong, 1992, Cancer.

Concurrent cetuximab, cisplatin, and radiotherapy (RT) for loco-regionally advanced squamous cell carcinoma of the head and neck (SCCHN): Updated results of a novel combined modality paradigm

J. Shah, M. Zelefsky, D. Kraus, 2005 .

Intensity-Modulated Radiation Therapy for Clinically Localized Prostate Cancer

M. Zelefsky, M. Kollmeier, 2014 .

Intensity-modulated radiotherapy.

E. Yorke, K. Rosenzweig, M. Zelefsky, 2002, Cancer journal.

Stereotactic radiosurgery: A new paradigm for melanoma and renal cell carcinoma spine metastases.

Y. Yamada, M. Zelefsky, M. Bilsky, 2010 .

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

D. Kuban, M. Kattan, C. Roehrborn, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors o f B iochemical O utcome W ith S alvage C onformal Radiotherapy A fter R adical P rostatectomy f or P rostate C ancer

E. Venkatraman, M. Zelefsky, S. Leibel, 2003 .

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer.

M. Kris, V. Rusch, M. Zelefsky, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

External beam radiotherapy for small cell carcinoma of the urinary bladder: The Memorial Sloan-Kettering experience.

M. Zelefsky, B. Bochner, D. Bajorin, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Refining the predictive power of the prostate-specific antigen.

M. Zelefsky, S. Leibel, Z. Fuks, 1993, International Journal of Radiation Oncology, Biology, Physics.

Statin use is associated with improved biochemical outcome after high-dose radiotherapy for clinically localized prostate cancer

M. Kattan, Y. Yamada, M. Zelefsky, 2003 .

Early Salvage Radiotherapy Following Radical Prostatectomy

M. Zelefsky, T. Wiegel, A. Briganti, 2014 .

Simultaneous MV‐kV imaging for intrafractional motion management during volumetric‐modulated arc therapy delivery*

Gig S Mageras, Pengpeng Zhang, Hai Pham, 2016, Journal of applied clinical medical physics.

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02

M. Zelefsky, 2004 .

A multi-institutional analysis of adjuvant and salvage radiotherapy after radical prostatectomy

D. Kuban, M. Zelefsky, C. Catton, 2004 .

Double-blind, randomized trial of granulocyte-colony stimulating factor (GCSF) versus (v.) placebo during postoperative radiation (RT) for advanced resectable squamous cell head and neck cancer (SCCHN): Impact on mucositis.

M. Zelefsky, G. Bosl, S. Lake, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In vivo dosimetry and seed localization in prostate brachytherapy with permanent implants

M. Zaider, M. Zelefsky, A. Rosenfeld, 2004, IEEE Transactions on Nuclear Science.

Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma.

J. Mechalakos, Y. Yamada, M. Zelefsky, 2012, International journal of radiation oncology, biology, physics.

Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy.

G. Cohen, M. Zelefsky, L. Dauer, 2016, Brachytherapy.

Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT

M. Zelefsky, M. Rosenblum, M. Morris, 2023, Journal of Neuro-Oncology.

Early observations of acute and chronic toxicity & psa response in patients with carcinoma of the prostate treated on a dose escalation study with 3D-CRT

R. Mohan, M. Zelefsky, C. Burman, 1994 .

Multi-Institutional Phase 2 Trial of High-Dose Stereotactic Body Radiation Therapy with Temporary Hydrogel Spacer for Low- and Intermediate-Risk Prostate Cancer

C. Roehrborn, M. Zelefsky, R. Hannan, 2017 .

A multi-institutional analysis of adjuvant and salvage radiotherapy after radical prostatectomy

D. Kuban, M. Zelefsky, C. Catton, 2004 .

The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.

D. Kuban, M. Zelefsky, A. Zietman, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High-risk prostate cancer: from definition to contemporary management.

M. Zelefsky, F. Montorsi, S. Boorjian, 2012, European urology.

Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.

Y. Yamada, M. Zelefsky, L. Happersett, 2011, European urology.

Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer.

M. Zelefsky, D. Spratt, B. Cox, 2013, International journal of radiation oncology, biology, physics.

Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy

M. Kattan, P. Scardino, M. Zelefsky, 2004 .

A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.

D. Kuban, C. Roehrborn, P. Scardino, 2008, Urology.

Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT.

Y. Yamada, M. Zaider, G. Cohen, 2008, Brachytherapy.

Measurement of Respiratory Motion of the Prostate in the Prone and Supine Orientations Using Respiratory Correlated Computed Tomography

M. Zelefsky, M. Lovelock, G. Mageras, 2005 .

Prostate Cancer: Radiation therapy

M. Zelefsky, M. Kollmeier, 2008 .

Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer.

M. Zelefsky, Jean B. Owen, Julia R. White, 2009, Journal of the American College of Radiology : JACR.

Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer

J. Humm, M. Zelefsky, M. Thor, 2023, The Journal of Nuclear Medicine.

Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.

M. Zelefsky, D. Kraus, N. Lee, 2011, International Journal of Radiation Oncology, Biology, Physics.

Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data

M. Zelefsky, X. Pei, S. McBride, 2019, Advances in radiation oncology.

Assessment of Prostate Cancer Patients’ Understanding of the IPSS Questionnaire

M. Zelefsky, A. Vickers, A. Tin, 2023, Advances in Radiation Oncology.

Urethral Alarm Probe for Permanent Prostate Implants

Marco Zaider, Michael L. F Lerch, Anatoly B. Rosenfeld, 2008 .

Baseline genomic and circulating tumor cell (CTC) correlative data from very high-risk (VHR), localized, node-negative prostate cancer patients.

M. Zelefsky, H. Scher, J. Hearn, 2019, Journal of Clinical Oncology.

The role of external beam in brachytherapy.

E. Yorke, M. Zaider, G. Cohen, 2007, Future oncology.

Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning.

G J Kutcher, S A Leibel, Z Fuks, 1997, International journal of radiation oncology, biology, physics.

Predicting the outcome of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

D. Kuban, M. Kattan, C. Roehrborn, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.

M. Zelefsky, D. Spratt, Z. Zumsteg, 2013, European urology.

Three-Dimensional Conformal Radiation Therapy at the Memorial Sloan-Kettering Cancer Center.

Mageras, M. Zelefsky, T. Losasso, 1992, Seminars in radiation oncology.

Brachytherapy and MRI: seeing what we are missing.

M. Zelefsky, N. Riaz, 2013, Brachytherapy.

Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer.

M. Zelefsky, W. Shi, X. Pei, 2016, Urology.

The management of the clinically positive neck as part of a larynx preservation approach.

R. Spiro, E. Strong, J. Shah, 1993, International journal of radiation oncology, biology, physics.

Five Year Update on Intraoperative Radiation Therapy for Breast Cancer

M. Zelefsky, K. Beal, B. McCormick, 2011 .

Rebuttal to Dr. Stone.

M. Zelefsky, D. Spratt, 2013, Brachytherapy.

Point / Counterpoint Rebuttal to Dr . Stone

M. Zelefsky, D. Spratt, 2022 .